OPKO Health

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OPKO Health and other ETFs, options, and stocks.

About OPK

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. 

CEO
Phillip Frost
CEOPhillip Frost
Employees
2,997
Employees2,997
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
1991
Founded1991
Employees
2,997
Employees2,997

OPK Key Statistics

Market cap
998.01M
Market cap998.01M
Price-Earnings ratio
-5.35
Price-Earnings ratio-5.35
Dividend yield
Dividend yield
Average volume
2.88M
Average volume2.88M
High today
$1.33
High today$1.33
Low today
$1.28
Low today$1.28
Open price
$1.32
Open price$1.32
Volume
900.25K
Volume900.25K
52 Week high
$2.04
52 Week high$2.04
52 Week low
$1.11
52 Week low$1.11

Stock Snapshot

The current OPKO Health(OPK) stock price is $1.30, with a market capitalization of 998.01M. The stock trades at a price-to-earnings (P/E) ratio of -5.35.

On 2025-11-13, OPKO Health(OPK) stock moved within a range of $1.28 to $1.33. With shares now at $1.30, the stock is trading +1.4% above its intraday low and -2.3% below the session's peak.

Trading activity shows a volume of 900.25K, compared to an average daily volume of 2.88M.

The stock's 52-week range extends from a low of $1.11 to a high of $2.04.

The stock's 52-week range extends from a low of $1.11 to a high of $2.04.

OPK News

Simply Wall St 2d
OPKO Health: Evaluating Valuation After Oncology Business Sale and Updated Earnings Guidance

OPKO Health (OPK) is in the spotlight after updating its earnings guidance for the fourth quarter, taking into account the recent sale of its oncology business....

OPKO Health: Evaluating Valuation After Oncology Business Sale and Updated Earnings Guidance
Simply Wall St 4d
Is OPKO Health's Post-Oncology Revenue Guidance Reset Shifting the Investment Case for OPK?

OPKO Health recently updated its fourth quarter 2025 earnings guidance to reflect the sale of its oncology business, projecting total revenue of US$135 million...

Is OPKO Health's Post-Oncology Revenue Guidance Reset Shifting the Investment Case for OPK?

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own OPK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.